In order to combat the immunostimulatory effects of the elevated extracellular ATP in the tumor microenvironment, tumor cells, and tumor-associated immune cells, can overexpress CD39 and/or CD73 to rapidly convert extracellular ATP into immunosuppressive adenosine (24). The gene discussed is NT5E; the disease is neoplasm.